FBRX - Forte Biosciences, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
14.19 -1.27 (-8.95%)	---	---	---	---	-1.27 (-8.95%)	0.0 (0.0%)	0.0 (0.0%)

Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.96
Diluted EPS:: -0.96
Basic P/E:: -13.4583
Diluted P/E:: -13.4583
RSI(14) 1m:: 70.69
VWAP:: 12.9
RVol:: 1.2718

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	12.95 -0.16 (-1.22%)	Oct 15 13:46
1m	Price increase 1m	13.23 +0.24 (+1.87%)	Oct 15 13:43
1m	Price decrease 1m	13.02 -0.14 (-1.06%)	Oct 15 13:11
1m	Price decrease 1m	13.3 -0.19 (-1.37%)	Oct 15 12:28
1m	Price decrease 1m	13.13 -0.19 (-1.43%)	Oct 15 12:06